Company Filing History:
Years Active: 2011
Title: Blandine Comte: Innovator in Biomarker Detection
Introduction
Blandine Comte is a notable inventor based in Montreal, Canada. She has made significant contributions to the field of biomedical research, particularly in the detection of oxidative stress biomarkers. Her innovative approach has the potential to enhance diagnostic methods in clinical settings.
Latest Patents
Blandine Comte holds a patent for a method titled "Method for detecting a biomarker of oxidative stress in a biological sample." This method involves dosing a ratio of HNE-to-DHN-protein in blood. It compares this ratio to a predetermined interval of ratio values associated with specific levels of oxidative stress. If the ratio falls within this interval, the oxidative stress is classified as having reached the predetermined level. This patent represents a significant advancement in understanding and measuring oxidative stress.
Career Highlights
Blandine Comte is affiliated with the Institut de Cardiologie de Montreal, where she applies her expertise in cardiovascular research. Her work focuses on developing innovative methods to improve patient outcomes through better diagnostic tools.
Collaborations
Blandine collaborates with esteemed colleagues, including Christine Des Rosiers and Caroline Asselin. These partnerships enhance her research efforts and contribute to the advancement of knowledge in her field.
Conclusion
Blandine Comte's contributions to the detection of oxidative stress biomarkers exemplify her commitment to innovation in biomedical research. Her work not only advances scientific understanding but also holds promise for improving clinical diagnostics.